Last reviewed · How we verify
NCT06205719
Effect of Remazolam on Anesthesia Recovery in Patients Undergoing Fundus Surgery
EARLY_PHASE1 trial testing ciprofol in Remazolam Anesthesia in 93 participants. Not yet recruiting.
30 May 2025
Quick facts
| Lead sponsor | Sichuan Provincial People's Hospital |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | screening |
| Enrollment | 93 |
| Start date | 1 June 2024 |
| Primary completion | 30 May 2025 |
| Estimated completion | 30 May 2026 |
Drugs / interventions tested
- ciprofol — full drug profile →
- Remazolam — full drug profile →
- Flumazenil (FLUMAZENIL) — full drug profile →
- Remifentanil — full drug profile →
Conditions studied
- Remazolam Anesthesia — all drugs for Remazolam Anesthesia →
- Postoperative Recovery — all drugs for Postoperative Recovery →
Sponsor
Sichuan Provincial People's Hospital
Who can join
Adults 18 to 65, any sex, with Remazolam Anesthesia or Postoperative Recovery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
to investigate the effect of remazolam benzenesulfonate in patients with ocular fundus surgery, so as to guide clinical anesthesiologists to choose more appropriate anesthetic drugs in fundus surgery
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06205719
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of ciprofol
Trials testing the same drug.
- NCT06976996 — Efficacy of Esketamine Combined With Different General Anesthetics on Quality of Postoperative Recovery · NA · active not recruiting
- NCT06425757 — Study on Pharmacokinetics of Single Injection of Ciprofol in Patients With Moderate to Severe Hypoproteinemia · Phase 4 · completed
- NCT06258967 — Ciprofol Titrated Induction in Reducing Post-induction Hypotension in Geriatric Patients · NA · unknown
- NCT05881291 — Efficacy and Safety of Ciprofol for General Anaesthesia in Patients Undergoing Transcatheter Aortic Valve Replacement · Phase 4 · completed
- NCT06287138 — The Effect of Ciprofol on Breathing Patterns, Respiratory Drive, and Inspiratory Effort in Mechanically Ventilated Patie · NA · unknown
Other Sichuan Provincial People's Hospital trials
Trials by the same sponsor.
- NCT07298525 — Safety Exploration and Evaluation of Dexmedetomidine Hydrochloride Nasal Spray for Pre-anesthesia Sedation in Low-Monito · Phase 4 · not yet recruiting
- NCT07175363 — Butorphanol for Pain Relief After Cesarean Section: A Retrospective Study · not yet recruiting
- NCT07106996 — Mechanism of Red Yeast Rice Regulating Intestinal Indole Metabolism Pathway to Improve Chronic Inflammation in Polycysti · EARLY_PHASE1 · recruiting
- NCT07082946 — Mechanisms of Perioperative Systemic Inflammation in the Development of PND in Cirrhotic Patients · not yet recruiting
- NCT06821633 — Investigating the Retardation Effect of OCTA-Guided Targeted Photocoagulation on the Progression of Non-Perfusion Areas · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06205719 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sichuan Provincial People's Hospital
- Last refreshed: 20 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06205719.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing